Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mometasone furoate + olopatadine hydrochloride
- Development stage
- Unknown
- Lead developer
- Daewoong Pharmaceutical
- Modality
- Small Molecules
- Administration
- Intranasal
01
Overview
Nasomega is an intranasal spray formulation combining the corticosteroid **mometasone furoate** and the antihistamine **olopatadine hydrochloride**. Developed by **Daewoong Pharmaceutical** (and partnered with **Great Bear Pharmaceutical** for certain markets), it is indicated for the treatment of symptoms associated with severe allergic rhinitis and nasal polyps. Mometasone furoate acts as an anti-inflammatory agent by binding to glucocorticoid receptors, reducing the production of inflammatory mediators. Olopatadine hydrochloride is a selective H1-receptor antagonist that inhibits the release of histamine from mast cells. The combination is designed to provide superior efficacy over monotherapy by addressing both the early-phase (histamine-mediated) and late-phase (inflammatory) responses of allergic rhinitis.
- Brand names
- Nasomega
- Other names
- Nasomega Nasal Spray
02
Targets
GR (Glucocorticoid receptor)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on mometasone furoate + olopatadine hydrochloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mometasone furoate + olopatadine hydrochloride.